(Q36244571)

13 August 2017

1 reference

title

Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management (English)

1 reference

13 August 2017

0 references

1

Dag Aarsland

1 reference

13 August 2017

3

Clive Ballard

1 reference

13 August 2017

Sally Sharp

2

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Current Neurology and Neuroscience Reports

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

345-354

1 reference

Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

Cholinergic deficits contribute to behavioral disturbance in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

Behavioral treatment of depression in dementia patients: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0058-4

Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

21 January 2018

1 reference

12 December 2020

One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study.

1 reference

12 December 2020

Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis.

1 reference

12 December 2020

Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.

1 reference

12 December 2020

Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease

1 reference

12 December 2020

Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data

1 reference

12 December 2020

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

12 December 2020

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

1 reference

12 December 2020

Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia

1 reference

12 December 2020

[3H]GR113808 binding to serotonin 5-HT(4) receptors in the postmortem neocortex of Alzheimer disease: a clinicopathological study.

1 reference

12 December 2020

Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease.

1 reference

12 December 2020

Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies

1 reference

12 December 2020

Noradrenergic changes, aggressive behavior, and cognition in patients with dementia

1 reference

12 December 2020

Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

12 December 2020

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

1 reference

12 December 2020

Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study

1 reference

12 December 2020

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.

1 reference

12 December 2020

Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

1 reference

12 December 2020

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias

1 reference

12 December 2020

Light Therapy for Managing Sleep, Behaviour, and Mood Disturbances in Dementia

1 reference

12 December 2020

Valproate preparations for agitation in dementia

1 reference

12 December 2020

5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease.

1 reference

12 December 2020

The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia

1 reference

12 December 2020

Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.

1 reference

12 December 2020

Atypical antipsychotics and risk of cerebrovascular accidents.

1 reference

12 December 2020

Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease

1 reference

12 December 2020

Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study

1 reference

12 December 2020

Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia

1 reference

12 December 2020

Do atypical antipsychotics cause stroke?

1 reference

12 December 2020

Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype

1 reference

12 December 2020

Influence of behavioral symptoms on rates of institutionalization for persons with Alzheimer's disease.

1 reference

12 December 2020

The effect of risperidone on nursing burden associated with caring for patients with dementia

1 reference

12 December 2020

The effect of a structured intervention on caregivers of patients with dementia and problem behaviors: a randomized controlled pilot study.

1 reference

12 December 2020

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

12 December 2020

Effect of the BACE intervention on agitation of people with dementia

1 reference

12 December 2020

Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study.

1 reference

12 December 2020

Growth hormone response to clonidine predicts aggression in Alzheimer's disease

1 reference

12 December 2020

The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease

1 reference

12 December 2020

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia.

1 reference

12 December 2020

Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism

1 reference

12 December 2020

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

1 reference

12 December 2020

Randomized controlled trial of different models of care for nursing home residents with dementia complicated by depression or psychosis

1 reference

12 December 2020

A randomized controlled trial of a home hospital intervention for frail elderly demented patients: behavioral disturbances and caregiver's stress.

1 reference

12 December 2020

Rivastigmine for dementia associated with Parkinson's disease

1 reference

12 December 2020

The effect of therapeutic touch on behavioral symptoms of persons with dementia

1 reference

12 December 2020

Depression in Alzheimer's disease: the effect of serotonin receptor gene variation

1 reference

12 December 2020

Frontotemporal dementia: a randomised, controlled trial with trazodone

1 reference

12 December 2020

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

1 reference

12 December 2020

A controlled trial of aromatherapy for agitation in nursing home patients with dementia

1 reference

12 December 2020

GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia

1 reference

12 December 2020

Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's disease

1 reference

12 December 2020

Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation

1 reference

12 December 2020

Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease

1 reference

12 December 2020

Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine

1 reference

12 December 2020

Behavioral and mood effects of snoezelen integrated into 24-hour dementia care.

1 reference

12 December 2020

Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease

1 reference

12 December 2020

Rivastigmine in frontotemporal dementia: an open-label study.

1 reference

12 December 2020

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

1 reference

12 December 2020

Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene

1 reference

12 December 2020

Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home residents with dementia.

1 reference

12 December 2020

Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients

1 reference

12 December 2020

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

1 reference

12 December 2020

Behavioural and psychological syndromes in Alzheimer's disease

1 reference

12 December 2020

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

1 reference

12 December 2020

Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial

1 reference

12 December 2020

Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs

1 reference

12 December 2020

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

1 reference

12 December 2020

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis

1 reference

12 December 2020

Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S11910-005-0058-4

Identifiers

DOI

1 reference

13 August 2017

1 reference